Related Experiment Videos
Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology
Alexandre G Z Rossi1, José M Soares, Eduardo L A Motta
1Department of Gynecology, Federal University of São Paulo, Escola Paulista de Medicina, São Paulo, Brazil. Jsoares415@aol.com
Gynecologic and Obstetric Investigation
|February 20, 2003
Summary
High prolactin levels, or pituitary hyperprolactinemia, stimulate endometrial proliferation in mice. This effect was most pronounced in young animals, suggesting age-related differences in response to elevated prolactin.
Area of Science:
- Reproductive Endocrinology
- Mouse Models in Biomedical Research
Background:
- Pituitary hyperprolactinemia's impact on the endometrium, particularly without amenorrhea, is not well understood.
- Prolactin is a hormone with known reproductive functions, but its direct endometrial effects require further elucidation.
Purpose of the Study:
- To investigate the effects of induced hyperprolactinemia on endometrial morphology in young and adult mice.
- To determine if elevated prolactin levels influence endometrial proliferation and gland development.
Main Methods:
- Induced hyperprolactinemia in young and adult mice using long-term metoclopramide (MC) treatment.
- Analyzed endometrial morphology via light microscopy, focusing on gland number, endometrial thickness, and diameter ratios.
Main Results:
- Metoclopramide-induced hyperprolactinemia led to increased endometrial gland counts in both young and adult mice compared to controls.
- Young MC-treated mice exhibited a significantly higher endometrial thickness index than other groups.
- Max/min diameter ratio of the endometrium was lower in young MC-treated mice than in adults.
Conclusions:
- Induced hyperprolactinemia promotes endometrial proliferation in mice.
- Younger animals demonstrate a more pronounced proliferative response to elevated prolactin levels.
- These findings contribute to understanding prolactin's role in endometrial changes.